-
BeiGene Terezumab has been approved by the European Commission for the treatment of non-small cell lung cancer
On April 25th, Southern Finance and Economics reported that the European Commission has approved the use of BeiGene Terezumab for first-line and second-line treatment of three indications for non-sma ...- Ronan62054
- 2024-4-25
- 지지
- 반대
- 답장
- 소장
-
Anjin small cell lung cancer treatment drug approved by FDA: can reduce tumor size and prolong lifespan
The US Food and Drug Administration (FDA) approved Amgen's treatment for lung cancer on Thursday (May 17). Tarlatamab is a bispecific T cell conjugator (BiTE) antibody developed by Amgen in the Unite ... -
AstraZeneca: Targeted lung cancer drug Teresa? Indications for first-line combined chemotherapy for advanced non-small cell lung cancer with EGFR mutation approved in China
According to AI News, AstraZeneca announced on June 26 that the National Medical Products Administration of China officially approved Teresa& on June 18, 2024; reg; The combination of pemetrexed and ... -
AstraZeneca Imfinzi approved by FDA for postoperative adjuvant therapy in non-small cell lung cancer patients
The US Food and Drug Administration (FDA) approved a new therapy for the best-selling anti-cancer drug Imfinzi from British pharmaceutical giant AstraZeneca on Thursday (August 15th). According to me ...